Trials / Completed
CompletedNCT06592339
A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)
An Open-Label, Randomized, Single-Dose, 3-Period, Crossover Study to Evaluate the Comparative Bioavailability of MK-0616 Capsules and Tablet Formulations in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of the study is to learn what happens to levels of MK-0616 in the blood when MK-0616 is given in different forms. Researchers believe that there is no effect on a healthy person's body if MK-0616 is given in different forms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-0616 | oral administration |
Timeline
- Start date
- 2022-10-25
- Primary completion
- 2022-12-29
- Completion
- 2022-12-29
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06592339. Inclusion in this directory is not an endorsement.